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The fetal protein fetuin has previously been considered to be confined to species of the order Artiodactyla 
(cattle, sheep, etc.) in spite of demonstrable biological in vitro effects in tissues of other species [(1983) 
Comp. Biochem. Physiol. 76A, 241-2451. We have determined the partial amino acid sequence of bovine 
fetuin and compared it with the published sequence of human +HS glycoprotein. The N-terminal 105 
residues and a segment aligned with residues 17&225 of arHS glycoprotein revealed 109 of 161 residues 
to be identical between the two proteins (68% homology). Mouse polyclonal antibodies to fetuin, and trypsin 
digest fragments of this protein have been prepared and used for a comparison of native and digested pro- 
teins. Polyclonal antibodies to native protein showed little if any cross reactivity. However, antibodies to 
trypsin digest fragments of fetuin showed obvious cross reactivity with azHS. 
Fetuin; a2HS glycoprotein; Development; (Fetus) 
1. INTRODUCTION 
The presence of high concentrations of some 
plasma proteins in developing tissues has suggested 
possible functions for these proteins [l]. In our im- 
munocytochemical studies of developing cortex in 
sheep and cattle we have noted a high concentra- 
tion of one particular glycoprotein, fetuin, in the 
immature cortical plate [2]. Recently we have ob- 
tained similar information on human developing 
brain; but in addition to rather weak staining for 
fetuin we obtained strong staining for another 
glycoprotein, cuz-HS glycoprotein [3]. The pub- 
lished first 44 amino acids of the N-terminal of 
fetuin [4] and the A chain of cvzHS glycoprotein [5] 
show about 60% homology. This prompted us to 
undertake a study to decide whether the two pro- 
teins (or part of them) may in fact be the same pep- 
tide. We investigated their relationship using 
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immunological methods as well as extending the 
partial amino acid sequence. 
2. MATERIALS AND METHODS 
2.1. Preparation of fragments of calf fetuin 
Calf fetuin was obtained from Calbiochem 
(no.341506). The protein was subjected to diges- 
tion with TPCK-treated trypsin (Sigma) and V8 
proteinase (Boehringer) using conditions essential- 
ly the same as those in [6]. Prior to enzyme diges- 
tion calf fetuin was reduced and S-carboxy- 
methylated and in one instance lysine groups were 
modified by succinylation prior to trypsin diges- 
tion using procedures described [a]. Dilute acid 
cleavage was carried out by incubating reduced 
and S-carboxymethylated fetuin (2 mg) in 0.5 ml 
of 10% acetic acid/6 M guanidine HCl (pH 
adjusted to 2.5 with pyridine) at 40°C for 96 h. 
All peptide fragments were isolated by reverse- 
phase HPLC, using an HPLC system similar to 
that in [a]. Trypsin and V8 proteinase derived pep- 
tides were subjected to initial separation on a 
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Radial-Pak PBondapak Cl8 (0.8 x 10 cm), a either with 50 /cg of 2 h trypsin digested fetuin (an- 
Bakerbond C8 (0.46 x 25 cm) or a Vydac Cl8 tiserum D) or 1OOpg of native protein (antiserum 
(0.46 x 25 cm) column using a solvent system F) in Freund’s complete adjuvant on day 0, 14 and 
generated from 0.1% TFA and 80% 28. 3 days after the last injection the mice were 
CH&N/O.l% TFA. In some cases additional bled and the specificity of the antiserum checked in 
purification of peptides was achieved using a crossed electrophoretic plates as described [9]. 
Radial-Pak PBondapak Cl8 column and a solvent Rabbit anti-calf fetuin was obtained from 
system derived from 0.1% NHdHC03 and 80% Dakopatts (Denmark) and rabbit anti-human 
CH3CN. cv2HS from Hoechst (FRG). 
Purification of acid-cleavage peptides was 
achieved by injecting an aliquot (0.4 ml) of the 
digest onto a Bakerbond C8 column (0.46 x 
25 cm) equilibrated with 20% propan-2-01/O. 1% 
TFA (solvent A) at a flow rate of 0.6 ml/min. A 
linear gradient of 140 min was applied to the col- 
umn to give a final concentration of 40% solvent 
A, and 60% solvent B (propan-Zol/O.l% TFA). 
Further purification was carried out using a 
Vydac-Phenyl column (0.46 x 25 cm) using a 
similar solvent system. 
2.4.2. SDS-polyacrylamide gel electrophoresis and 
immunoblotting 
All peptides were detected by absorbance at 
214 nm. 
2.2. Amino acid analysis and automated 
N-terminal sequence analysis 
Amino acid analysis was carried out using the 
procedure of Bidlingmeyer et al. [7]. Automated 
sequence determination was carried out using an 
Applied Biosystems sequencer (model 470 A) 
essentially as described by Hewick et al. [8]. 
Phenylthiohydantoin amino acid derivatives were 
identified by HPLC using a Nova-Pak Cl8 column 
(0.46 x 15 cm) following the procedure recom- 
mended by the manufacturers (Waters Associates, 
MA). 
Samples of fetuin (5 pg), LYZHS glycoprotein 
(5 fig) and limited tryptic digests of these proteins 
(20/1g) were each subjected to electrophoresis on 
15% acrylamide gels under reducing conditions in 
the presence of SDS [lo]. Following elec- 
trophoretic transfer of protein bands to nitro- 
cellulose [l l] additional protein binding sites were 
blocked by incubation with 3% gelatin in TBS 
(20 mM Tris-HCI, 0.5 M NaCl, pH 7.4) for 1 h. 
The paper was then incubated with a 1: 100 dilu- 
tion of mouse D or F antiserum for 1 h and finally 
with anti-mouse IgG antiserum conjugated with 
horseradish peroxidase (Dakopatts, Denmark). 
Antibody dilutions were in TBS containing 1% 
gelatin and 0.05% Tween 20. In between antibody 
incubations the nitrocellulose was washed, briefly, 
with distilled water and two 10 min washes with 
TBS/O.OS% Tween 20. After the final antibody in- 
cubation the nitrocellulose was washed with TBS 
and peroxidase activity visualized using 0.2 mg/ml 
diaminobenzidine/0.005 % Hz02 in TBS. 
3. RESULTS 
2.3. Limited proteolysis of calf fetuin and human 
CYZHS glycoprotein with trypsin 
Limited proteolysis was carried out by dissolving 
fetuin and cv2HS glycoprotein at a concentration of 
5 mg/ml in 0.1 M NH4HCO3 and incubating with 
TPCK-treated trypsin (Sigma, enzyme to substrate 
ratio of 1: 100, v/v) for 2 h at 37°C. Digests were 
either stored frozen or aliquots were freeze-dried. 
3.1. Amino acid sequences of fetuin 
The partial sequence of fefuin was obtained by 
automated amino acid sequence of intact fetuin 
and fragments generated by trypsin, V8 proteinase 
and dilute acid cleavage and this is compared with 
that of human CYU~HS glycoprotein in fig. 1. 
2.4. Immunological comparison of bovine fetuin 
and human CVZHS 
2.4.1. Antibodies against fetuin and fetuin 
fragments 
Balb/c mice were injected intraperitoneally 
The previously published N-terminal sequence 
of calf fetuin [4] has been extended to 105 residues 
and of these, 75 residues were also found in the 
a2HS glycoprotein sequence (7 1% homology). 
Peptide T26 A3 was positioned by homology with 
a2HS glycoprotein; this is supported by the amino 
acid composition of peptide V8 40, which cor- 
responds to residues 21-58 of fetuin (not shown). 
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Fig. 1. Comparison of partial sequence of calf fetuin with human cu2HS glycoprotein. T, tryptic peptides; TS, tryptic 
peptide from succinylated fetuin; V8, VS-protease peptide; AC, peptide generated by dilute acid cleavage. Residues are 
in the single letter code: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H. His; I, Be; K, Lys; L, Leu; N, Asn; P, 
Pro; Q, Glu; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; X, unknown; Y, Tyr. Residues in the cvzHS glycoprotein sequence 
[5] which differ from fetuin are noted above the fetuin sequence. 
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A further segment of 56 residues was antiserum but reacted clearly with D antiserum 
homologous to residues 170-225 of the human which was raised against a sample of fetuin that 
~zHS glycoprotein sequence with 34 out of 56 had been subjected to limited proteolysis with tryp- 
residues (61%) being identical. The positioning of sin. On the other hand, both D and F antisera 
peptide V8 12/l was based on homology. recognized partially digested ~zHS. 
3.2. Immunological comparison of fetuin and 
azHS glycoprotein 
In order to determine immunologically how 
closely azHS and fetuin are related we used mouse 
polyclonal antisera to native and peptide 
fragments of fetuin. It has previously been shown, 
using crossed immunoelectrophoresis, that rabbit 
anti-bovine fetuin cross reacts with rwzHS but rab- 
bit anti_cuzHS does not cross react with fetuin [3]. 
Intact fetuin and (u~HS glycoprotein and fragments 
generated from these proteins by limited pro- 
teolysis with trypsin were compared by im- 
munoblotting using mouse polyclonal D and F 
antisera (fig.2). Limited proteolysis resulted in the 
appearance of a 30 kDa fragment of fetuin which 
was recognized by both antisera. Native ~zHS 
glycoprotein showed no cross reactivity with the F 
Fig.2. Comparison of calf fetuin and human cvzHS and 
their limited trypsin digests by immunoblotting. Samples 
of untreated proteins and trypsin digest were run on 
15% acrylamide gels in the presence of SDS and proteins 
transferred to nitrocellulose. Immunological detection 
used mouse anti-fetuin D and F sera as the primary 
antisera. Molecular mass marker proteins were bovine 
serum albumin (66 kDa). ovalbumin (44 kDa), 
trypsinogen (24 kDa), soybean trypsin inhibitor 
(20 kDa) and lactalbumin (14 kDa). (a) Fetuin, (b) 
cu2HS. 0, native protein; 2 h, 2 h trypsin digested 
protein; D, antiserum against trypsin digested fetuin; F, 
antiserum against native fetuin. 
4. DISCUSSION 
Sequence homologies amongst different proteins 
have revealed interesting relationships between 
structure and function [ 11. In other cases a high 
degree of homology at the level of amino acid and 
DNA sequence has been used to group proteins in- 
to families although there is no obvious similarity 
in their known functions (e.g. albumin, cy- 
fetoprotein and Gc-globulin [12]). In the present 
paper a striking similarity in amino acid sequence 
between a human plasma protein, cvzHS glycopro- 
tein and a bovine fetal protein, fetuin, is 
demonstrated. We have previously commented on 
the similarity between the amino acid composition 
of these two proteins and their similar distributions 
in the developing brain [3]. The complete amino 
acid sequence of cvzHS has been published [5]: we 
have now obtained the partial sequence of fetuin 
including the first 105 residues and a segment 
which was aligned with residues 170-225 of CXZHS 
glycoprotein. The homology between the A chain 
of HS and the partial sequence of fetuin is 68%. 
Cysteine and tryptophan residues are conserved 
and there are few substitutions which introduce 
charge differences between the two proteins. Most 
of the substitutions (38 out of 49) can be explained 
by single base pair changes. From the degree of 
homology it is probable that fetuin and cu2HS have 
originated from a common ancestral gene [l]. 
The antigenic relationships between fetuin and 
a2HS glycoprotein have been i vestigated. In order 
to distinguish whether the tertiary rather than 
primary structure of the protein is responsible for 
the antibody response to fetuin [3], we have ob- 
tained antibodies to trypsin digested fetuin. Using 
these antibodies it was possible to demonstrate 
clearly that fetuin and human CQ-HS are related 
proteins, although the antigenic determinants of 
both proteins seem to be different. 
Comparison of the sequence of fetuin fragments 
and (YzHS A chain with protein sequences in a data 
bank demonstrated some similarity to the C- 
terminus of human crz-macroglobulin [ 131 
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although at a low level of significance (26% identi- 
ty in 62 amino acids overlap). However, this may 
be of considerable interest, since our D antiserum 
(against trypsin digested fetuin) cross reacts 
strongly with human cuz-macroglobulin, a finding 
that is currently being investigated. 
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